Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;20(4):579-585.
doi: 10.1038/s41397-020-0148-3. Epub 2020 Jan 17.

SWEDEGENE-a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions

Pär Hallberg  1 , Qun-Ying Yue  2 , Erik Eliasson  3 , Håkan Melhus  4 , Joel Ås  4 , Mia Wadelius  4
Affiliations

SWEDEGENE-a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions

Pär Hallberg et al. Pharmacogenomics J. 2020 Aug.

Abstract

SWEDEGENE is a Swedish nation-wide sample collection established to facilitate studies of clinical and genetic risk factors for adverse drug reactions (ADRs). Most cases are recruited among patients reported to the ADR registry at the Swedish Medical Products Agency by health-care professionals. Clinical data are collected both from medical and laboratory records and through interviews using standardized questionnaires. Genome-wide scans and whole-genome sequencing are done, and association studies are conducted using mainly controls from the Swedish TwinGene biobank with data on diagnoses and prescribed drugs. SWEDEGENE was established in 2008 and currently contains DNA and information from about 2550 adults who have experienced specific ADRs, and from 580 drug exposed controls. Results from genome-wide association studies have now been published, and data from whole-genome sequencing are being analyzed. SWEDEGENE has the potential to offer a new means of developing individualized and safe drug therapy through patient pre-treatment screening.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

    1. Odar-Cederlof I, Oskarsson P, Ohlen G, Tesfa Y, Bergendal A, Hellden A, et al. [Adverse drug effect as cause of hospital admission. Common drugs are the major part according to the cross-sectional study] Lakartidningen. 2008;105:890–3. - PubMed
    1. von Euler M, Eliasson E, Ohlen G, Bergman U. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiology drug Saf. 2006;15:179–84. doi: 10.1002/pds.1154. - DOI - PubMed
    1. Lundkvist J, Jonsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharm. 2004;18:275–80. doi: 10.1111/j.1472-8206.2004.00239.x. - DOI - PubMed
    1. Fryckstedt J, Asker-Hagelberg C. [Drug-related problems common in the emergency department of internal medicine. The cause of admission in almost every third patient according to quality follow-up]. Lakartidningen. 2008;105:894–8. - PubMed
    1. Wester K, Jonsson AK, Spigset O, Druid H, Hagg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharm. 2008;65:573–9. doi: 10.1111/j.1365-2125.2007.03064.x. - DOI - PMC - PubMed

Publication types

MeSH terms